{"id":"9cc07364-27ac-4ecf-8cb4-10bec5d57464","url":"https://japan.cnet.com/release/31169326/","domain":"japan.cnet.com","outlet":{"name":"Cnet","country":null,"cred":null,"lean":null,"curated":false},"title":"J&J、IBD患者さんを支援する取り組み「Dual Control～治療と仕事の両立～」の一環で「I-BUDDY」を始動","plainHeadline":null,"rewrite":{"model":null,"at":null},"summary":["1. Johnson & Johnson launches 'I-BUDDY' to support IBD patients.","2. The initiative is part of 'Dual Control' for balancing treatment and work.","3. Over 60% of IBD patients are unaware of 'endoscopic remission'.","4. Endoscopic remission reduces symptom worsening risk by 68% for UC patients.","5. For CD patients, achieving remission lowers surgery needs by one-third.","6. The program emphasizes shared decision-making between patients and healthcare providers.","7. 'I-BUDDY' aims to help patients achieve personal goals and improve quality of life."],"topics":["Health"],"lang":"eng","publishedAt":"2026-05-19T04:00:00.000Z","ingestedAt":"2026-05-19T04:54:27.069Z","story":null}